The Globalists’ In Plain Sight Host Christine Dolan will be covering ALL THINGS PFIZER with Sasha Latypova.
Going forward CDMedia will be collaborating with Sasha Latypova to bring to light everything about PHARMA connected to COVID-19.
Latypova is an accomplished business owner and executive whose experience spans 25 years in PHARMA R&D, technology and data analysis. She has worked in econometrics and litigation support for PHARMA and healthcare clients.
A co-founder of several venture capital-backed companies in clinical research and technology space via technology transfer from academic research, Latypova has worked on 100’s of clinical trials for about 60 PHARMA companies globally. She has worked with Pfizer extensively as a client and an investor up to approximately 2013. Between 2006 -2017 her focus was on cardiovascular safety assessments for new drugs, and has interacted with the FDA, and co-led an industry-FDA consortium investigating new technologies.
Latypova became increasingly concerned realizing there was an orchestrated campaign against hydroxychloroquine as a viable and safe treatment option during covid. She initiated a study into VAERS on the vials resulting in injuries and fraud covering both scientific and regulatory, and possibly adulterated manufacturing of the mRNA “vaccines”, whether it is intentional or poorly controlled.